High expression of TM4SF1 predicts a poor prognosis in many types of cancer, such as glioma, colorectal cancer, breast cancer, and ovarian cancer, but predicts a good prognosis in gastric cancer, pancreatic cancer, breast cancer, and malignant pleural mesothelioma [10]. Here, TM4SF1 is linked to central nervous system cancer.